+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Agenus Inc - logo

Agenus is an immuno-oncology company that focuses on the discovery and development of treatments that engage the body's immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates. It is also developing Prophage, a heat shock protein-based autologous vaccine. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Leiomyosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Leiomyosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 152 Pages
  • Global
From
PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032 - Product Thumbnail Image

PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032

  • Report
  • September 2022
  • 247 Pages
  • Global
From
Plant-based Vaccines Global Market Report 2024 - Product Thumbnail Image

Plant-based Vaccines Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Vaccine Adjuvants Global Market Report 2024 - Product Thumbnail Image

Vaccine Adjuvants Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Vaccine Adjuvant Market: Trends, Opportunities and Competitive Analysis 2023-2028 - Product Thumbnail Image

Vaccine Adjuvant Market: Trends, Opportunities and Competitive Analysis 2023-2028

  • Report
  • April 2023
  • 150 Pages
  • Global
From
Global Vaccine Adjuvants Market Report by Product Type, Route of Administration, Diseases, Application, and Region 2023-2028 - Product Thumbnail Image

Global Vaccine Adjuvants Market Report by Product Type, Route of Administration, Diseases, Application, and Region 2023-2028

  • Report
  • November 2023
  • 147 Pages
  • Global
From
Therapeutic Vaccine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Therapeutic Vaccine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 120 Pages
  • Global
From
Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 532 Pages
  • Global
From
Regulatory T-Cell Therapies Market by Target Indications, Key Players and Key Geographies: Industry Trends and Global Forecast, 2021-2035 - Product Thumbnail Image

Regulatory T-Cell Therapies Market by Target Indications, Key Players and Key Geographies: Industry Trends and Global Forecast, 2021-2035

  • Report
  • October 2021
  • 145 Pages
  • Global
From
Fc Fusion Therapeutics Market by Target Indications, Type of Fusion Molecule, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Fc Fusion Therapeutics Market by Target Indications, Type of Fusion Molecule, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • September 2021
  • 150 Pages
  • Global
From
Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 700 Pages
  • Global
From
Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030 - Product Thumbnail Image

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

  • Report
  • February 2020
  • 360 Pages
  • Global
From
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 - Product Thumbnail Image

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

  • Report
  • November 2020
  • 450 Pages
  • Global
From
Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • December 2023
  • 265 Pages
  • Global
From
Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 734 Pages
  • Global
From
Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 322 Pages
  • Global
From
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Global CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market 2024-2028 - Product Thumbnail Image

Global CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market 2024-2028

  • Report
  • December 2023
  • 163 Pages
  • Global
From
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1588 Pages
  • Global
From
Hepatitis A Virus Cellular Receptor 2 - Pipeline Review, H2 2019 - Product Thumbnail Image

Hepatitis A Virus Cellular Receptor 2 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 83 Pages
  • Global
From
Loading Indicator